Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
64Cu-GRIP B PET Imaging in Advanced Malignancies
NCT05888532Phase 2Recruiting
- Sponsor
- Rahul Aggarwal
- Start
- May 2023
- Primary completion
- Dec 2026
- Modality
- Peptide-Drug Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of 64Cu-GRIP B in solid tumor, renal cell carcinoma (RCC), urothelial carcinoma (UC), prostate cancer (PCa), sponsored by Rahul Aggarwal. Started May 2023; status: recruiting.
02
Drugs
64Cu-GRIP B
03
Conditions
solid tumorrenal cell carcinoma (RCC)urothelial carcinoma (UC)prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05888532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05888532.